FDA Urged To Articulate Policy On Clinical Decision Support Software
This article was originally published in The Gray Sheet
Executive Summary
The topic of clinical decision support software does not belong in FDA guidance on mobile health applications and should be addressed, as soon as possible, in separate guidance, stakeholders say.